blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0512090

EP0512090 - TREATMENT OF INFLAMMATION [Right-click to bookmark this link]
StatusPatent maintained as amended
Status updated on  20.10.2006
Database last updated on 25.09.2024
Most recent event   Tooltip15.11.2013Lapse of the patent in a contracting statepublished on 18.12.2013  [2013/51]
Applicant(s)For all designated states
Sonoran Desert Chemicals LLC
4250 N. Drinkwater Blvd., 4th floor
Scottsdale, Arizona 85251 / US
[2003/22]
Former [1992/46]For all designated states
Lezdey, John
976 Kingston Drive
Cherry Hill, New Jersey 08034 / US
For all designated states
Wachter, Allan
9822 South Grandview
Tempe, Arizona 85284 / US
Inventor(s)01 / Lezdey, John
976 Kingston Drive
Cherry Hill, New Jersey 08034 / US
02 / Wachter, Allan M.
9822 South Grandview
Tempe, Arizona 85284 / US
 [2003/22]
Former [1992/46]01 / see applicant
...
Representative(s)Bassett, Richard Simon, et al
Potter Clarkson LLP The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
[N/P]
Former [2001/29]Bassett, Richard Simon, et al
Eric Potter Clarkson, Park View House, 58 The Ropewalk
Nottingham NG1 5DD / GB
Former [1992/46]Onn, Thorsten, et al
AB STOCKHOLMS PATENTBYRA Box 23101
S-104 35 Stockholm / SE
Application number, filing date91920172.326.09.1991
[1992/46]
WO1991US06847
Priority number, dateUS1990059824116.10.1990         Original published format: US 598241
US1991064372718.01.1991         Original published format: US 643727
US1991068362011.04.1991         Original published format: US 683620
[1992/46]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9206706
Date:30.04.1992
Language:EN
[1992/10]
Type: A1 Application with search report 
No.:EP0512090
Date:11.11.1992
Language:EN
The application published by WIPO in one of the EPO official languages on 30.04.1992 takes the place of the publication of the European patent application.
[1992/46]
Type: B1 Patent specification 
No.:EP0512090
Date:02.01.1997
Language:EN
[1997/01]
Type: B2 New European patent specification 
No.:EP0512090
Date:22.11.2006
Language:EN
[2006/47]
Search report(s)International search report - published on:US30.04.1992
(Supplementary) European search report - dispatched on:EP15.03.1993
ClassificationIPC:A61K38/55, A61K31/56
[1993/18]
CPC:
B82Y5/00 (EP); A61K38/57 (EP)
C-Set:
A61K38/55, A61K31/57 (EP);
A61K38/57, A61K2300/00 (EP)
Former IPC [1992/46]A61K37/64, A61K31/56
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1992/46]
TitleGerman:BEHANDLUNG VON ENTZÜNDUNGEN[1992/46]
English:TREATMENT OF INFLAMMATION[1992/46]
French:TRAITEMENT D'INFLAMMATIONS[1992/46]
Entry into regional phase09.09.1992National basic fee paid 
09.09.1992Search fee paid 
09.09.1992Designation fee(s) paid 
09.09.1992Examination fee paid 
Examination procedure09.09.1992Examination requested  [1992/46]
17.05.1993Request for accelerated examination filed
18.04.1995Despatch of a communication from the examining division (Time limit: M08)
18.04.1995Decision about request for accelerated examination - accepted: Yes
17.10.1995Reply to a communication from the examining division
25.10.1995Despatch of a communication from the examining division (Time limit: M02)
30.10.1995Reply to a communication from the examining division
13.11.1995Despatch of a communication from the examining division (Time limit: M02)
13.12.1995Reply to a communication from the examining division
07.05.1996Despatch of communication of intention to grant (Approval: Yes)
27.06.1996Communication of intention to grant the patent
06.09.1996Fee for grant paid
06.09.1996Fee for publishing/printing paid
23.09.1996Observations by third parties
Opposition(s)Opponent(s)01  25.09.1997  08.12.1997  ADMISSIBLE
ZLB Behring GmbH
Postfach 1230
35002 Marburg / DE
Opponent's representative
Lauppe, Hans Friedrich
ZLB Behring GmbH
Postfach 12 30
35002 Marburg / DE
 02  02.10.1997  08.12.1997  ADMISSIBLE
Genzyme Transgenics Corporation
Five Mountain Road
Framingham, MA 01701 / US
Opponent's representative
Ruffles, Graham Keith
Marks & Clerk LLP 62-68 Hills Road Cambridge
CB2 1LA / GB
 03  02.10.1997  08.12.1997  ADMISSIBLE
Bayer AG
Konzernbereich RP Patente und Lizenzen
51368 Leverkusen / DE
Opponent's representative
Chapman, Paul William
Kilburn & Strode LLP
20 Red Lion Street
London
WC1R 4PJ / GB
 [N/P]
Former [2008/33]
Opponent(s)01  25.09.1997  08.12.1997  ADMISSIBLE
ZLB Behring GmbH
Postfach 1230
35002 Marburg / DE
Opponent's representative
Lauppe, Hans Friedrich, Dr.
ZLB Behring GmbH, Postfach 12 30
35002 Marburg / DE
 02  02.10.1997  08.12.1997  ADMISSIBLE
Genzyme Transgenics Corporation
Five Mountain Road
Framingham, MA 01701 / US
Opponent's representative
Ruffles, Graham Keith
Marks & Clerk 62-68 Hills Road
Cambridge CB2 1LA / GB
 03  02.10.1997  08.12.1997  ADMISSIBLE
Bayer AG
Konzernbereich RP Patente und Lizenzen
51368 Leverkusen / DE
Opponent's representative
Chapman, Paul William
Kilburn & Strode, 20 Red Lion Street
London WC1R 4PJ / GB
Former [2005/14]
Opponent(s)01  25.09.1997  08.12.1997  ADMISSIBLE
ZLB Behring GmbH
Postfach 1230
35002 Marburg / DE
Opponent's representative
Lauppe, Hans Friedrich, Dr.
ZLB Behring GmbH, Postfach 12 30
35002 Marburg / DE
 02  02.10.1997  08.12.1997  ADMISSIBLE
Genzyme Transgenics Corporation
Five Mountain Road
Framingham, MA 01701 / US
Opponent's representative
Ruffles, Graham Keith
Marks & Clerk 66-68 Hills Road
Cambridge, Cambridgeshire, CB2 1LA / GB
 03  02.10.1997  08.12.1997  ADMISSIBLE
Bayer AG
Konzernbereich RP Patente und Lizenzen
51368 Leverkusen / DE
Opponent's representative
Chapman, Paul William
Kilburn & Strode, 20 Red Lion Street
London WC1R 4PJ / GB
Former [2005/09]
Opponent(s)01  25.09.1997  08.12.1997  ADMISSIBLE
AVENTIS BEHRING GMBH
Postfach 1230
35002 MARBURG / DE
Opponent's representative
Lauppe, Hans Friedrich, Dr.
Aventis Behring GmbH, Postfach 12 30
35002 Marburg / DE
 02  02.10.1997  08.12.1997  ADMISSIBLE
Genzyme Transgenics Corporation
Five Mountain Road
Framingham, MA 01701 / US
Opponent's representative
Ruffles, Graham Keith
Marks & Clerk 66-68 Hills Road
Cambridge, Cambridgeshire, CB2 1LA / GB
 03  02.10.1997  08.12.1997  ADMISSIBLE
Bayer AG
Konzernbereich RP Patente und Lizenzen
51368 Leverkusen / DE
Opponent's representative
Chapman, Paul William
Kilburn & Strode, 20 Red Lion Street
London WC1R 4PJ / GB
Former [2001/45]
Opponent(s)01  25.09.1997  08.12.1997  ADMISSIBLE
AVENTIS BEHRING GMBH
Postfach 1230
35002 MARBURG / DE
Opponent's representative
Lauppe, Hans Friedrich, Dr.
Aventis Behring GmbH, Postfach 12 30
35002 Marburg / DE
 02  02.10.1997  08.12.1997  ADMISSIBLE
Genzyme Transgenics Corporation
Five Mountain Road
Framingham, MA 01701 / US
Opponent's representative
Ruffles, Graham Keith
MARKS & CLERK, 57-60 Lincoln's Inn Fields
London WC2A 3LS / GB
 03  02.10.1997  08.12.1997  ADMISSIBLE
Bayer AG
Konzernbereich RP Patente und Lizenzen
51368 Leverkusen / DE
Opponent's representative
Chapman, Paul William
Kilburn & Strode, 20 Red Lion Street
London WC1R 4PJ / GB
Former [1997/50]
Opponent(s)01  25.09.1997   
CENTEON PHARMA GMBH
Postfach 1230
35002 MARBURG / DE
Opponent's representative
Lauppe, Hans Friedrich
Aventis Behring GmbH, Postfach 12 30
35002 Marburg / DE
 02  02.10.1997   
Genzyme Transgenics Corporation
Five Mountain Road
Framingham, MA 01701 / US
Opponent's representative
Ruffles, Graham Keith
Marks & Clerk LLP 62-68 Hills Road Cambridge
CB2 1LA / GB
 03  02.10.1997    ADMISSIBLE
Bayer AG
Konzernbereich RP Patente und Lizenzen
51368 Leverkusen / DE
Opponent's representative
Chapman, Paul William
Kilburn & Strode LLP 20 Red Lion Street London
WC1R 4PJ / GB
Former [1997/48]
Opponent(s)01  25.09.1997   
CENTEON PHARMA GMBH
Postfach 1230
35002 MARBURG / DE
Opponent's representative
Lauppe, Hans Friedrich
Aventis Behring GmbH, Postfach 12 30
35002 Marburg / DE
 02  02.10.1997    ADMISSIBLE
Genzyme Transgenics Corporation
Five Mountain Road
Framingham, MA 01701 / US
Opponent's representative
Ruffles, Graham Keith
Marks & Clerk LLP 62-68 Hills Road Cambridge
CB2 1LA / GB
Former [1997/47]
Opponent(s)01  25.09.1997   
CENTEON PHARMA GMBH
Postfach 1230
35002 MARBURG / DE
Opponent's representative
Lauppe, Hans Friedrich
Aventis Behring GmbH, Postfach 12 30
35002 Marburg / DE
11.12.1997Invitation to proprietor to file observations on the notice of opposition
10.06.1998Reply of patent proprietor to notice(s) of opposition
08.03.2001Date of oral proceedings
08.05.2001Despatch of minutes of oral proceedings
09.05.2005Despatch of interlocutory decision in opposition
09.05.2005Legal effect of interlocutory decision in opposition
07.07.2006Despatch of communication that the patent will be maintained as amended
06.10.2006Fee for printing new specification paid
Appeal following opposition05.07.2001Appeal received No.  T0676/01
07.09.2001Statement of grounds filed
09.05.2005Result of appeal procedure: maintenance in amended form
15.06.2001Appeal received No.  T0676/01
07.09.2001Statement of grounds filed
05.06.2002Invitation to file observations in an appeal (Time limit: M02) [2002/23]
26.07.2002Date of receipt of observations in an appeal [2002/30]
19.12.2002Invitation to file observations in an appeal (Time limit: M02) [2002/51]
18.02.2003Date of receipt of observations in an appeal [2003/08]
09.05.2005Date of oral proceedings
18.05.2005Minutes of the oral proceedings despatched
Fees paidRenewal fee
30.09.1993Renewal fee patent year 03
29.09.1994Renewal fee patent year 04
28.09.1995Renewal fee patent year 05
30.09.1996Renewal fee patent year 06
Penalty fee
Penalty fee Rule 85a EPC 1973
21.08.1992AT   M01   Fee paid on   09.09.1992
21.08.1992BE   M01   Fee paid on   09.09.1992
21.08.1992CH   M01   Fee paid on   09.09.1992
21.08.1992DE   M01   Fee paid on   09.09.1992
21.08.1992DK   M01   Fee paid on   09.09.1992
21.08.1992ES   M01   Fee paid on   09.09.1992
21.08.1992FR   M01   Fee paid on   09.09.1992
21.08.1992GB   M01   Fee paid on   09.09.1992
21.08.1992GR   M01   Fee paid on   09.09.1992
21.08.1992IT   M01   Fee paid on   09.09.1992
21.08.1992LU   M01   Fee paid on   09.09.1992
21.08.1992NL   M01   Fee paid on   09.09.1992
21.08.1992SE   M01   Fee paid on   09.09.1992
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipGB26.09.2006
LU26.09.2006
SE27.09.2006
CH30.09.2006
LI30.09.2006
DK02.10.2006
FR02.10.2006
BE31.10.2006
[2013/51]
Former [2010/05]GB26.09.2006
LU26.09.2006
SE27.09.2006
CH30.09.2006
LI30.09.2006
DK02.10.2006
FR02.10.2006
BE31.10.2006
Former [2008/36]GB26.09.2006
LU26.09.2006
SE27.09.2006
CH30.09.2006
LI30.09.2006
DK02.10.2006
FR02.10.2006
Former [2008/23]GB26.09.2006
SE27.09.2006
CH30.09.2006
LI30.09.2006
DK02.10.2006
FR02.10.2006
Former [2008/02]GB26.09.2006
SE27.09.2006
CH30.09.2006
LI30.09.2006
DK02.10.2006
Former [2007/29]SE27.09.2006
Documents cited:Search[A]EP0139383  (ZYMOGENETICS INC [US]);
 [X]US4916117  (LEZDEY JOHN [US], et al);
 [XP]EP0432117  (LEZDEY JOHN [US], et al)
 [Y]  - BIOL. CHEM. HOPPE-SEYLER, VOL. 371, SUPPL. May 1990, BERLIN, FRG pages 75 - 79 S.C. DIETZE ET AL. 'Inhibition of Histamine Release from Human Mast Cells Ex Vivo by Natural and Synthetic Chymase Inhibitors'
 [Y]  - JOURNAL OF BIOLOGICAL CHEMISTRY. (MICROFILMS) vol. 264, no. 35, 15 December 1989, BALTIMORE, MD US pages 21308 - 21315 N.M. SCHECHTER ET AL. 'Reaction of Human Skin Chymotrypsin-like Proteinase Chymase with Plasma Proteinase Inhibitors'
International search[X]  - Biochemical Medicine and Metabolic Biology, Volume 38, issued 1987, FUKUSEN et al., "Kinetic Studies on the Inhibitions of Mast Cell Chymase by Natureal Serine Protease Inhibitiors: Indications for Potential Biological Functions of these Inhibitors", pp 165-169, see entire documents.
 [Y]  - J Clin, Invest., Vol. 71, issued June 1983, Schleimer et al., "Effects of Dexamethasone on Mediator Release from Human Lung Fragments and Purified Human Lung Mast Cells", pp 1830-1835, see entire document.
 [Y]  - Am. Rev. Respir. Dis, Vol. 135, suppl., issued 1987, WASSERMAN, "The Regulation of Inflammatory mediator Production by Mast Cell Products", pp S46-S48, see entire document.
 [Y]  - Clinical Immunology and Immunopathology, Vol. 50, suppl., issued 1989, MARONE et al., "Pathophysiology of Human Basophils and Mast Cells in Allergic Disorders", pp. S24-S40, see entire document.
 [Y]  - Annals of Allergy, Vol. 63, No. 6, Suppl., issued 1989, WASSERMAN, "Mast Cell-mediated inflammation in Asthma", pp. S46-S50, see entire document.
 [Y]  - Ann. Rev. Immunol., Vol. 1, issued 1983, LARSEN et al., "Mediators of Inflammation", pp 335-359, see entire document.
ExaminationEP0139383
 EP0432117
OppositionEP0289336
 EP0304971
 US5093316
    - Annals of Internal Medicine 1989, 111(3), pp. 206-212
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.